# Altheus Therapeutics Inc — Form D/A

Altheus Therapeutics Inc of Oklahoma City, OK, a company, filed a Form D amendment with the SEC on 2011-12-08. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2011-12-08
- Form: D/A
- Accession: 0001140361-11-056653
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $2.0M
- Minimum investment: $947
- Investors: 11
- Date of first sale: 2009-05-01
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-109372

## Issuer

- Name: Altheus Therapeutics Inc
- CIK: 0001414163
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2006
- Address: 755 Research Parkway, Oklahoma City, OK, 73104
- Phone: (405) 319-8180

## Officers, directors & promoters (19)

| Name | Role | Location |
| --- | --- | --- |
| Alpha A BioPartners, Inc. | Promoter | Palo Alto, CA |
| William Paiva | Director | Broken Arrow, OK |
| Dennis Schafer | Director | Amsterdam, P7 |
| Dennis Schafer | Executive Officer | Amsterdam, P7 |
| William A Paiva | Director | Tulsa, OK |
| Douglas A Branch | Director | OKLAHOMA CITY, OK |
| Douglas A Branch | Executive Officer | OKLAHOMA CITY, OK |
| William L Paiva | Director | Tulsa, OK |
| Dayton T Reardan | Executive Officer | Oklahoma City, OK |
| Alpha BioPartners Inc. | Promoter | Palo Alto, CA |
| Brian L Clevinger | Director | St. Louis, MO |
| Brian L Clevinger | Executive Officer | St. Louis, MO |
| Dennis L Schafer | Director | Oklahoma City, OK |
| Dennis L Schafer | Executive Officer | Oklahoma City, OK |
| Thomas L Shoaf | Director | St. Louis, MO |
| Richard F Harty, MD | Executive Officer | Oklahoma City, OK |
| Richard F Harty, MD | Promoter | Oklahoma City, OK |
| James L Schoeneck | Director | San Diego, CA |
| James Schoeneck | Director | San Diego, CA |

## Other filings by this issuer (8)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2014-01-23](https://search.stillhousedata.com/formd/0001140361-14-003026) | D/A | $8.1M | $8.1M |
| [2013-10-25](https://search.stillhousedata.com/formd/0001140361-13-039588) | D/A | $8.2M | $6.9M |
| [2013-01-04](https://search.stillhousedata.com/formd/0001140361-13-001149) | D/A | $5.9M | $5.9M |
| [2012-03-09](https://search.stillhousedata.com/formd/0001140361-12-014470) | D | $7.7M | $5.3M |
| [2011-07-13](https://search.stillhousedata.com/formd/0001140361-11-036680) | D/A | $1.8M | $1.8M |
| [2010-06-04](https://search.stillhousedata.com/formd/0001414163-10-000001) | D/A | $1.7M | $1.7M |
| [2009-10-05](https://search.stillhousedata.com/formd/0001414163-09-000003) | D/A | $1.2M | $1.2M |
| [2009-05-11](https://search.stillhousedata.com/formd/0001414163-09-000002) | D | $1.2M | $500K |

## More

- [CIK 1414163 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1414163&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-11-056653.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.